Blog & Commentary
Simmons Hanly Conroy’s support blog is a place for clients and families to find news, education, and inspirational stories about the following areas of litigation: mesothelioma and asbestos, dangerous drugs and devices, consumer protection and mass torts, personal injury and environmental litigation.
Blog
Mesothelioma Caregiver Tips for the New Year
January 2015 marks the beginning of a new year and a time to start fresh. Whether you believe in New Year’s Resolutions or not, this is the perfect time to set new… Read More
Meet the Attorney: Trent Miracle
Attorney Trent Miracle decided to become a lawyer because he wanted to help people who have the odds stacked against them. “You are not alone, but you alone can make the decision… Read More
Get to Know the Simmons Hanly Conroy Shareholders – Part 3
Once a month, we have been sharing some facts about each of shareholders who make up the Simmons Hanly Conroy family. Now it’s time to introduce the rest. Our goal is to… Read More
Mesothelioma and Women: The Truth Behind Take-Home Exposure
Many asbestos occupations like auto mechanics, construction workers and oil refinery workers were made up of predominantly male employees. For this reason, a large portion of patients who are diagnosed with mesothelioma… Read More
The Must-Know Facts about Blood-Thinning Medications
Blood thinning medications are used to prevent blood clots. Blood clots are health risks that increase chances of stroke, heart attack, and various other health issues. Warfarin is one of the original… Read More
Pharmaceutical News Wrap Up: December 2014
The pharmaceutical attorneys at Simmons Hanly Conroy understand the importance of staying up to date on the latest headlines. Below is a list of some of the most recent pharmaceutical news concerning… Read More
Asbestos and Mesothelioma News Wrap Up: December 2014
The mesothelioma lawyers at Simmons Hanly Conroy understand the importance of staying up to date on the latest asbestos and mesothelioma news. Below is a group of some of the most recent… Read More
FDA Advisers Shown to Have Questionable Financial Ties
In July 2014, an adviser on a U.S. Food and Drug Administration (FDA) gynecology panel stepped down after he was questioned about conflicts of interest. It was later discovered that this panel… Read More
The History of Risperdal FDA Warnings
Risperdal was approved by the U.S. Food and Drug Administration (FDA) in 1994. It is recognized as a medication used to treat psychological issues. The antipsychotic drug is approved for use in patients… Read More
Get to Know the Simmons Hanly Conroy Shareholders – Part 2
In October, we introduced ten members of the Simmons Hanly Conroy leadership team. Now it’s time to introduce ten more. By getting to know our shareholders, you can see for yourself the… Read More
